Piroska Pázmány

Piroska Pázmány

Auto-generated profile, based on publicly available information

Piroska Pázmány

Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary; Heim Pál National Pediatrics Institute, Budapest, Hungary; Doctoral School of Clinical Medicine, University of Szeged, Szeged Hungary, Hungary

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2022 in Medical Science Monitor
Verified
Journal Article
Open access
ÁMÁgnes Rita Martonosi
Ágnes Rita Martonosi
PPPiroska Pázmány
Piroska Pázmány
SKSzabolcs Kiss
Szabolcs Kiss
FDFanni Dembrovszky
Fanni Dembrovszky
EOEduard Oštarijaš
Eduard Oštarijaš
LSLászló Szabó
László Szabó
Urodynamics in Early Diagnosis of Diabetic Bladder Dysfunction in Women: A Systematic Review and Meta-Analysis - Article abstract #937166

26 November 2024 in Pancreatology
Verified
Journal Article
Open access
PPPiroska Pázmány
Piroska Pázmány
AKAnna Kanjo
Anna Kanjo
ZMZsanett Macht-Szalai
Zsanett Macht-Szalai
NGNoémi Gede
Noémi Gede
NFNelli Farkas
Nelli Farkas
ZMZsolt Molnar
Zsolt Molnar
Acute pancreatitis (AP) can rapidly progress from a stable condition to multiple organ failure with high mortality. We aimed to describe the characteristics of AP patients requiring admission to a critical care facility and to identify predictors of disease progression. We conducted a post-hoc analysis using prospectively collected data from AP patients admitted to the high dependency unit (HDU) and intensive care unit (ICU) at the University of Pécs, Hungary, from 2016 to 2019. Patients were categorized according to critical care needs and severity. Daily records of organ function, organ support and laboratory parameters were kept. Descriptive analysis and predictive models were developed to forecast the need for escalated critical care and mortality. Analysis of 92 cases (65 % male, mean age 63 (range 19-92) years) revealed a median critical care stay of 8 days (range 1-69) and a mortality rate of 47 %. Naive Bayes prediction models using admission C-reactive protein (CRP) and amylase levels achieved 75 % accuracy in predicting mortality and a 65 % probability of requiring HDU and/or ICU admission. CRP levels increased significantly (47 vs 62 mg/l, p: 0.015) from 48 to 24 h before critical care admission, contrasting with controls, resulting in significantly higher CRP levels in critical care patients (62 vs 32 mg/l, p: 0.007) 24 h before admission. Our findings suggest that on-admission CRP and amylase cannot reliably predict progression of AP. However, elevated and increasing levels of CRP and amylase may indicate the need for early HDU admission to enable closer monitoring.

27 December 2022 in Neurourology and Urodynamics
Verified
Journal Article
Open access
ÁMÁgnes Rita Martonosi
Ágnes Rita Martonosi
PPPiroska Pázmány
Piroska Pázmány
SKSzabolcs Kiss
Szabolcs Kiss
MFMária Földi
Mária Földi
Annamária ZsákaiAnnamária Zsákai
Annamária Zsákai
LSLászló Szabó
László Szabó
Aims: To establish normal reference values of urine flow acceleration (Qacc) in healthy children, as there is a lack of nomograms for normative reference values of Qacc by voided volumes in the pediatric population so far. Qacc might be an early indicator of autonomic neuropathy in children and adolescents.Methods: Data were retrospectively collected from healthy children who underwent uroflowmetry between 1990 and 1992. Exclusion criteria were voided volume less than 20 ml, and postvoid residual more than 15%. Baseline characteristics and uroflowmetry parameters were collected from girls and boys aged between 6 and 18 years. Voided volume, voiding time, time to maximum flow rate, and maximum and average flow rates of urine were measured, and Qacc was calculated. Postvoid bladder diameter was measured by ultrasonography and converted to volume.Results: Uroflowmetry parameters of 208 children (≤18 years old, 45.2% girls, mean age 9.68 ± 3.09 years) who performed 404 micturition were analyzed. Median voided volume, voiding time, time to Qmax, Qave, Qmax, Qacc, and postvoid residual volume were 130 [20–460] ml, 10 [3–56] s, 3 [1–14] s, 11.7 [2.5–36.6] ml/s, 20.5 [5–50] ml/s, 6 [0.81–25] ml/s2, and 1.83 [0–38.62] ml, respectively. Qacc nomograms were given in centile forms for girls and boys separately, which show an inversely proportional correlation between voided volumes.Conclusions: These are the first nomograms for normative reference values of Qacc in the pediatric population (girls and boys separately) by voided volumes in centile forms. These may be useful to interpret abnormal Qacc values and diagnose lower urinary tract diseases over a wide range of voided volumes.

14 November 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
ÁMÁgnes Rita Martonosi
Ágnes Rita Martonosi
PPPiroska Pázmány
Piroska Pázmány
SKSzabolcs Kiss
Szabolcs Kiss
Annamária ZsákaiAnnamária Zsákai
Annamária Zsákai
LSLászló Szabó
László Szabó
Introduction: Bladder emptying abnormalities and cardiovascular autonomic dysfunction are manifestations of autonomic dysfunction in people with diabetes mellitus (DM), which are major causes of morbidity and mortality. Since they can reduce the quality of life, they are urgent to be addressed before resulting in complications. As uroflowmetry might determine autonomic neuropathy earlier than cardiovascular autonomic dysfunction symptoms occur, our aim is to detect early abnormalities in bladder muscle function in children with DM. We investigate the diagnostic accuracy of uroflowmetry. As a secondary aim, we compare the prevalence of uroflowmetry abnormalities to the appearance of measures of cardiovascular autonomic neuropathy. Finally, as an ancillary study, we examine the association of uroflowmetry with the appearance of peripheral neuropathy. These three aims, we feel, will put our results regarding uroflowmetry into an overall context of nerve disease early in the course of type 1 DM. To our knowledge, such an approach has heretofore not been performed. Methods and analysis: This will be a prospective, observational, single-centre clinical study. Patients with DM fulfilling the inclusion criteria and healthy controls will have uroflowmetry examination, cardiovascular autonomic dysfunction tests (heart rate response to deep breathing, to Valsalva manoeuvre, blood pressure and heart rate response to standing up, and to sustained handgrip) and nerve conduction test. The autonomic nervous system function will be examined by the reproducible and standardised cardiovascular reflex tests described by Ewing et al . During the examination, electrocardiogram (ECG) and blood pressure values will be recorded continuously. Heart rate response to deep inspiration will be executed to investigate the parasympathetic nervous system. Peripheral neuropathy will be evaluated by nerve conduction test. After a pilot period, when the first 50 diabetic and 50 healthy children will be assessed, sample size calculation will be carried out. The primary objective of this trial is to evaluate the diagnostic accuracy (sensitivity, specificity, positive and negative predictive value) of uroflowmetry. To do so, we compare uroflowmetry to the gold standard neuropathy tests, which are cardiovascular autonomic dysfunction tests (heart rate response to deep breathing, to Valsalva manoeuvre, blood pressure and heart rate response to standing up and to sustained handgrip). Ethics and dissemination: Ethics approval was obtained from the Scientific and Research Ethics Committee of the Heim Pál National Paediatric Institute in Budapest, Hungary (registration number KUT-37/2021). Results will be submitted for publication in a peer-reviewed journal. Trial registration number: NCT05247840 .